KINEPOLIS (KIN.BR) Stock Fundamental Analysis

EBR:KIN • BE0974274061

27.05 EUR
+0.2 (+0.74%)
Last: Feb 18, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

KIN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 49 industry peers in the Entertainment industry. There are concerns on the financial health of KIN while its profitability can be described as average. KIN is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • KIN had positive earnings in the past year.
  • KIN had a positive operating cash flow in the past year.
  • In multiple years KIN reported negative net income over the last 5 years.
  • KIN had a positive operating cash flow in 4 of the past 5 years.
KIN.BR Yearly Net Income VS EBIT VS OCF VS FCFKIN.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

  • The Return On Assets of KIN (4.54%) is better than 73.47% of its industry peers.
  • KIN's Return On Equity of 23.61% is fine compared to the rest of the industry. KIN outperforms 79.59% of its industry peers.
  • The Return On Invested Capital of KIN (8.28%) is better than 75.51% of its industry peers.
  • KIN had an Average Return On Invested Capital over the past 3 years of 6.76%. This is below the industry average of 9.38%.
  • The last Return On Invested Capital (8.28%) for KIN is above the 3 year average (6.76%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.54%
ROE 23.61%
ROIC 8.28%
ROA(3y)3.57%
ROA(5y)0.53%
ROE(3y)21.42%
ROE(5y)-2.24%
ROIC(3y)6.76%
ROIC(5y)N/A
KIN.BR Yearly ROA, ROE, ROICKIN.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

  • KIN's Profit Margin of 7.98% is fine compared to the rest of the industry. KIN outperforms 73.47% of its industry peers.
  • KIN's Profit Margin has declined in the last couple of years.
  • KIN has a Operating Margin of 15.19%. This is amongst the best in the industry. KIN outperforms 89.80% of its industry peers.
  • KIN's Operating Margin has declined in the last couple of years.
  • KIN has a worse Gross Margin (24.54%) than 83.67% of its industry peers.
  • KIN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 15.19%
PM (TTM) 7.98%
GM 24.54%
OM growth 3YN/A
OM growth 5Y-4.79%
PM growth 3YN/A
PM growth 5Y-6.62%
GM growth 3Y115.73%
GM growth 5Y-3.42%
KIN.BR Yearly Profit, Operating, Gross MarginsKIN.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • KIN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for KIN remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for KIN has been increased compared to 5 years ago.
  • Compared to 1 year ago, KIN has an improved debt to assets ratio.
KIN.BR Yearly Shares OutstandingKIN.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
KIN.BR Yearly Total Debt VS Total AssetsKIN.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • Based on the Altman-Z score of 1.49, we must say that KIN is in the distress zone and has some risk of bankruptcy.
  • KIN has a Altman-Z score of 1.49. This is in the better half of the industry: KIN outperforms 61.22% of its industry peers.
  • KIN has a debt to FCF ratio of 5.38. This is a neutral value as KIN would need 5.38 years to pay back of all of its debts.
  • The Debt to FCF ratio of KIN (5.38) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 2.87 is on the high side and indicates that KIN has dependencies on debt financing.
  • KIN has a worse Debt to Equity ratio (2.87) than 69.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.87
Debt/FCF 5.38
Altman-Z 1.49
ROIC/WACC1.38
WACC5.98%
KIN.BR Yearly LT Debt VS Equity VS FCFKIN.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

  • KIN has a Current Ratio of 0.47. This is a bad value and indicates that KIN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • KIN has a Current ratio of 0.47. This is amonst the worse of the industry: KIN underperforms 87.76% of its industry peers.
  • KIN has a Quick Ratio of 0.47. This is a bad value and indicates that KIN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of KIN (0.44) is worse than 87.76% of its industry peers.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.44
KIN.BR Yearly Current Assets VS Current LiabilitesKIN.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 34.32% over the past year.
  • Measured over the past years, KIN shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.80% on average per year.
  • Looking at the last year, KIN shows a small growth in Revenue. The Revenue has grown by 5.38% in the last year.
  • The Revenue has been growing slightly by 0.95% on average over the past years.
EPS 1Y (TTM)34.32%
EPS 3YN/A
EPS 5Y-5.8%
EPS Q2Q%5581.82%
Revenue 1Y (TTM)5.38%
Revenue growth 3Y29.47%
Revenue growth 5Y0.95%
Sales Q2Q%6.22%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.94% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 4.98% on average over the next years.
EPS Next Y19.98%
EPS Next 2Y25.83%
EPS Next 3Y21.15%
EPS Next 5Y14.94%
Revenue Next Year3.49%
Revenue Next 2Y9.56%
Revenue Next 3Y7.85%
Revenue Next 5Y4.98%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
KIN.BR Yearly Revenue VS EstimatesKIN.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
KIN.BR Yearly EPS VS EstimatesKIN.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 -2

More info and screens

Find the best growth stocksShow best growing peers

8

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 15.82, which indicates a correct valuation of KIN.
  • Based on the Price/Earnings ratio, KIN is valued cheaper than 93.88% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of KIN to the average of the S&P500 Index (27.27), we can say KIN is valued slightly cheaper.
  • A Price/Forward Earnings ratio of 10.19 indicates a reasonable valuation of KIN.
  • KIN's Price/Forward Earnings ratio is rather cheap when compared to the industry. KIN is cheaper than 85.71% of the companies in the same industry.
  • KIN is valuated cheaply when we compare the Price/Forward Earnings ratio to 28.16, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.82
Fwd PE 10.19
KIN.BR Price Earnings VS Forward Price EarningsKIN.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • 71.43% of the companies in the same industry are more expensive than KIN, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of KIN indicates a rather cheap valuation: KIN is cheaper than 83.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 5.67
EV/EBITDA 8.01
KIN.BR Per share dataKIN.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as KIN's earnings are expected to grow with 21.15% in the coming years.
PEG (NY)0.79
PEG (5Y)N/A
EPS Next 2Y25.83%
EPS Next 3Y21.15%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 1.44%, KIN has a reasonable but not impressive dividend return.
  • KIN's Dividend Yield is a higher than the industry average which is at 0.88.
  • Compared to the average S&P500 Dividend Yield of 1.84, KIN is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.44%

5.2 History

  • The dividend of KIN decreases each year by -3.32%.
Dividend Growth(5Y)-3.32%
Div Incr Years1
Div Non Decr Years2
KIN.BR Yearly Dividends per shareKIN.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • 31.09% of the earnings are spent on dividend by KIN. This is a low number and sustainable payout ratio.
DP31.09%
EPS Next 2Y25.83%
EPS Next 3Y21.15%
KIN.BR Yearly Income VS Free CF VS DividendKIN.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
KIN.BR Dividend Payout.KIN.BR Dividend Payout, showing the Payout Ratio.KIN.BR Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

KINEPOLIS

EBR:KIN (2/18/2026, 7:00:00 PM)

27.05

+0.2 (+0.74%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-21
Earnings (Next)02-20
Inst Owners17.67%
Inst Owner ChangeN/A
Ins Owners1.8%
Ins Owner ChangeN/A
Market Cap740.36M
Revenue(TTM)593.29M
Net Income(TTM)47.32M
Analysts86
Price Target46.46 (71.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.44%
Yearly Dividend0.54
Dividend Growth(5Y)-3.32%
DP31.09%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.76%
PT rev (3m)-5.43%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.37%
EPS NY rev (3m)-5.43%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.12%
Valuation
Industry RankSector Rank
PE 15.82
Fwd PE 10.19
P/S 1.25
P/FCF 5.67
P/OCF 4.27
P/B 3.69
P/tB 33.03
EV/EBITDA 8.01
EPS(TTM)1.71
EY6.32%
EPS(NY)2.65
Fwd EY9.81%
FCF(TTM)4.77
FCFY17.64%
OCF(TTM)6.34
OCFY23.43%
SpS21.68
BVpS7.32
TBVpS0.82
PEG (NY)0.79
PEG (5Y)N/A
Graham Number16.79
Profitability
Industry RankSector Rank
ROA 4.54%
ROE 23.61%
ROCE 11.27%
ROIC 8.28%
ROICexc 8.93%
ROICexgc 11.76%
OM 15.19%
PM (TTM) 7.98%
GM 24.54%
FCFM 22.02%
ROA(3y)3.57%
ROA(5y)0.53%
ROE(3y)21.42%
ROE(5y)-2.24%
ROIC(3y)6.76%
ROIC(5y)N/A
ROICexc(3y)7.02%
ROICexc(5y)N/A
ROICexgc(3y)8.91%
ROICexgc(5y)N/A
ROCE(3y)9.19%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-1%
ROICexc growth 3YN/A
ROICexc growth 5Y-1.69%
OM growth 3YN/A
OM growth 5Y-4.79%
PM growth 3YN/A
PM growth 5Y-6.62%
GM growth 3Y115.73%
GM growth 5Y-3.42%
F-Score8
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 2.87
Debt/FCF 5.38
Debt/EBITDA 3.35
Cap/Depr 52.23%
Cap/Sales 7.23%
Interest Coverage 4.1
Cash Conversion 100.75%
Profit Quality 276.05%
Current Ratio 0.47
Quick Ratio 0.44
Altman-Z 1.49
F-Score8
WACC5.98%
ROIC/WACC1.38
Cap/Depr(3y)43.12%
Cap/Depr(5y)41.32%
Cap/Sales(3y)6.29%
Cap/Sales(5y)10.19%
Profit Quality(3y)301.12%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.32%
EPS 3YN/A
EPS 5Y-5.8%
EPS Q2Q%5581.82%
EPS Next Y19.98%
EPS Next 2Y25.83%
EPS Next 3Y21.15%
EPS Next 5Y14.94%
Revenue 1Y (TTM)5.38%
Revenue growth 3Y29.47%
Revenue growth 5Y0.95%
Sales Q2Q%6.22%
Revenue Next Year3.49%
Revenue Next 2Y9.56%
Revenue Next 3Y7.85%
Revenue Next 5Y4.98%
EBIT growth 1Y16.5%
EBIT growth 3YN/A
EBIT growth 5Y-3.89%
EBIT Next Year104.02%
EBIT Next 3Y35.57%
EBIT Next 5Y22.36%
FCF growth 1Y30.27%
FCF growth 3Y19%
FCF growth 5Y6.53%
OCF growth 1Y26.43%
OCF growth 3Y22.57%
OCF growth 5Y1.63%

KINEPOLIS / KIN.BR FAQ

Can you provide the ChartMill fundamental rating for KINEPOLIS?

ChartMill assigns a fundamental rating of 4 / 10 to KIN.BR.


Can you provide the valuation status for KINEPOLIS?

ChartMill assigns a valuation rating of 8 / 10 to KINEPOLIS (KIN.BR). This can be considered as Undervalued.


What is the profitability of KIN stock?

KINEPOLIS (KIN.BR) has a profitability rating of 5 / 10.


What are the PE and PB ratios of KINEPOLIS (KIN.BR) stock?

The Price/Earnings (PE) ratio for KINEPOLIS (KIN.BR) is 15.82 and the Price/Book (PB) ratio is 3.69.


Is the dividend of KINEPOLIS sustainable?

The dividend rating of KINEPOLIS (KIN.BR) is 3 / 10 and the dividend payout ratio is 31.09%.